BridgeMD
New treatment option for Esophageal Cancer
Official title Molecular Assessment for Gastro-Esophageal Cancer
ClinicalTrials.gov ID: NCT06346054
What this study is testing
- What it's testing
- The goal of this minimally invasive interventional study is to learn if oncometabolic biomarkers, detected in the exhaled breath and blood can identify early-stage gastro-oesophageal cancer in patient at risk for gastro-oesophageal cancer. The main questions this study aims to answer: Are oncometabolites proficient and reproducible enough to function as diagnostic biomarkers?
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 100. Healthy volunteers may be eligible.
You may be able to join if
- Voluntary written informed consent of the participant or their legally authorized representative has been obtained prior to any breath or blood...
- \>18 years old
- Barrett's esophagus or treatment naïve gastro-esophageal cancer stage I to IV
- Voluntary healthy controls
You likely can't join if
- \<18 years old
- Patient has history of:
- Active other cancer than gastro-esophageal cancer
- Prior cancer treated \<3 years ago
- Hepatic dysfunction/liver failure (MELT \>7)
- Any disorder, which in the investigator's opinion might jeopardise participant's safety or compliance with the study plan.
See the full eligibility criteria
- Voluntary written informed consent of the participant or their legally authorized representative has been obtained prior to any breath or blood analysis
- \>18 years old
- Barrett's esophagus or treatment naïve gastro-esophageal cancer stage I to IV
- Voluntary healthy controls
- \<18 years old
- Patient has history of:
- Active other cancer than gastro-esophageal cancer
- Prior cancer treated \<3 years ago
- Hepatic dysfunction/liver failure (MELT \>7)
- Any disorder, which in the investigator's opinion might jeopardise participant's safety or compliance with the study plan.
- Insufficient/unreliable quality of breath (e.g., breath flow) or plasma sample (e.g., haemolytic sample)
- Incarcerated individuals
The study team makes the final eligibility decision.
Where it's taking place
- Leuven, Belgium
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 100 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Leuven, Belgium. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.